PAS
IPSC icon

Point72 Asia (Singapore)’s Century Therapeutics IPSC Stock Holding History

Point72 Asia (Singapore)’s Portfolio IPSC Stock Details IPSC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$8.89K Sell
17,861
-19,023
-52% -$10.3K ﹤0.01% 786
2025
Q2 		$20.6K Buy
+36,884
New +$19.8K ﹤0.01% 728

Other funds holding IPSC

BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
SP
Syncona Portfolio St Peter Port, Guernsey $25.7M AUM 13.32% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Point72 Asia (Singapore)'s IPSC Position: Q3 2025 in Review

Point72 Asia (Singapore) reduced its Century Therapeutics (IPSC) stake by 52% in Q3 2025, selling an estimated $10.3K and leaving 17,861 shares worth $8.89K. The position accounts for ﹤0.01% of the portfolio, ranked #786.

Point72 Asia (Singapore) first reported a position in IPSC in Q2 2025 and has held it in 2 quarters since. The position peaked at $20.6K in Q2 2025. 57 funds tracked by Wall St. Rank hold IPSC as of Q3 2025.

  • Point72 Asia (Singapore) held 17,861 shares of Century Therapeutics worth $8.89K as of Q3 2025.
  • Point72 Asia (Singapore) sold 19,023 Century Therapeutics shares in Q3 2025, an estimated $10.3K.
  • Century Therapeutics made up ﹤0.01% of Point72 Asia (Singapore)'s portfolio in Q3 2025, its #786 holding.
  • Point72 Asia (Singapore) first reported a position in Century Therapeutics in Q2 2025 and has held it in 2 quarters since.
  • Point72 Asia (Singapore)'s Century Therapeutics position peaked at $20.6K in Q2 2025.
  • 57 funds tracked by Wall St. Rank held Century Therapeutics as of Q3 2025.

Based on Point72 Asia (Singapore)'s 13F filing for Q3 2025, filed 14 Nov 2025.